Nitric oxide inhibits capcitative Ca2+ entry and enhances endoplasmic reticulum Ca2+ uptake in bovine vascular endothelial cells

Journal of Physiology

Volumn 539, Issue 1, 2002, Pages 77-91

  Dedkova, Elena N ^a   Blatter, Lothar A ^a,b  

^a LOYOLA UNIVERSITY CHICAGO   (United States)

^b LOYOLA UNIVERSITY CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1H 1,2,4 OXADIAZOLO[4,3 A]QUINOXALIN 1 ONE; 8 BROMO CYCLIC AMP; ADENOSINE TRIPHOSPHATASE (CALCIUM); BIOLOGICAL MARKER; CALCIUM ION; CALMODULIN; CYCLIC GMP; FLUORESCENT DYE; HEMOGLOBIN; NITRIC OXIDE; NITRIC OXIDE DONOR; NITRIC OXIDE SYNTHASE; NITROPRUSSIDE SODIUM; SCAVENGER; 4,5 DIAMINOFLUORESCEIN DIACETATE; 8 BROMO CYCLIC GMP; ENDOTHELIAL NITRIC OXIDE SYNTHASE; FURA 2; FURAPTRA; PLASMA MEMBRANE CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE;

ANIMAL CELL; ANIMAL CELL CULTURE; ARTICLE; AUTOREGULATION; CALCIUM CELL LEVEL; CALCIUM HOMEOSTASIS; CALCIUM TRANSPORT; CATTLE; CELL MEMBRANE; CELL MEMBRANE PERMEABILITY; CELL TYPE; CONTROLLED STUDY; ENDOPLASMIC RETICULUM; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME INHIBITION; INCUBATION TIME; NEGATIVE FEEDBACK; NONHUMAN; PRIORITY JOURNAL; VASCULAR ENDOTHELIUM; AUTOCRINE EFFECT; BIOSYNTHESIS; CALCIUM DEPLETION; CALF (BOVINE); DOWN REGULATION; FLUORESCENCE; INTRACELLULAR TRANSPORT; PARACRINE SIGNALING; PULMONARY ARTERY; TRANSPORT KINETICS; VASCULAR ENDOTHELIAL CELL;

ADENOSINE TRIPHOSPHATE; ANIMALS; CALCIUM; CALCIUM-TRANSPORTING ATPASES; CATTLE; CELLS, CULTURED; CYCLIC GMP; ENDOPLASMIC RETICULUM; ENDOTHELIUM, VASCULAR; ENZYME INHIBITORS; INTRACELLULAR MEMBRANES; NITRIC OXIDE; NITROPRUSSIDE; OSMOLAR CONCENTRATION; THAPSIGARGIN;

EID: 0037085510     PISSN: 00223751     EISSN: None     Source Type: Journal    
DOI: 10.1113/jphysiol.2001.013258     Document Type: Article

References (58)

1. ASSREUY, J., CUNHA, F. Q., LIEW, F. Y. & MONCADA, S. (1993). Feedback inhibition of nitric oxide synthase activity by nitric oxide. British Journal of Pharmacology 108, 833-837.
2. 2+ and nitric oxide: A new method. Cell Calcium 25, 281-286.
3. BERKELS, R., SUERHOFF, S., ROESEN, R. & KLAUS, W. (2000b). Nitric oxide causes a cGMP-independent intracellular calcium rise in porcine endothelial cells - a paradox? Microvascular Research 59, 38-44.
4. 2+ entry into colonic epithelial cells by NO and cGMP. Cell Calcium 17, 250-262.
5. 2+ influx in HEK 293 cells? Cell Calcium 21, 135-142.
6. 2+ and nitric oxide in bradykinin-stimulated vascular endothelial cells. Circulation Research 76, 922-924.
7. i in vascular smooth muscle by inhibition of the calcium current. Cell Calcium 15, 122-131.
8. BOLZ, S. S. & POHL, U. (1997). Indomethacin enhances endothelial NO release - evidence for a role of PGI2 in the autocrine control of calcium-dependent autacoid production. Cardiovascular Research 36, 437-444.
9. BRORSON, J. R., SCHUMACKER, P. T. & ZHANG, H. (1999). Nitric oxide inhibits neuronal energy production. Journal of Neuroscience 19, 147-158.
10. BUGA, G. M., GRISCAVAGE, J. M., ROGERS, N. E. & IGNARRO, L. J. (1993). Negative feedback regulation of endothelial cell function by nitric oxide. Circulation Research 73, 808-812.
11. 2+-activated K channels. American Journal of Physiology 273, H76-84.
12. CAVALLINI, L., COASSIN, M., BOREAN, A. & ALEXANDRE, A. (1996). Prostacyclin and sodium nitroprusside inhibit the activity of the platelet mositol 1,4,5-trisphosphate receptor and promote its phosphorylation. Journal of Biological Chemistry 271, 5545-5551.
13. 2+ homeostasis in vascular endothelial cells. Journal of Biological Chemistry 275, 28739-28749.
14. 2+ mobilization and cytoskeletal F-actin filaments in human cerebromicrovascular endothelial cells. Journal of Cerebral Blood Flow and Metabolism 19, 133-138.
15. 2+ homeostasis. Biochemical Pharmacology 55, 713-718.
16. 2+ release in neurosecretory PC-12 cells: Inhibition of phospholipase C activity via cyclic GMP-dependent protein kinase 1. Molecular Pharmacology 47, 517-524.
17. 2+ influx. Circulation Research 84, 210-219.
18. 2+ by atriopeptin and 8-bromo-cyclic GMP is mediated by cyclic GMP-dependent protein kinase. Journal of Biological Chemistry 264, 1146-1155.
19. CORNWELL, T. L., PRYZWANSKY, K. B., WYATT, T. A. & LINCOLN, T. M. (1991). Regulation of sarcoplasmic reticulum protein phosphorylation by localized cyclic GMP-dependent protein kinase in vascular smooth muscle cells. Molecular Pharmacology 40, 923-931.
20. 2+ entry in vascular endothelial cells. Biophysical Journa1 80, 617a.
21. FORSTERMANN, U., CLOSS, E. I., POLLOCK, J. S., NAKANE, M., SCHWARZ, P., GATH, I. & KLEINERT, H. (1994). Nitric oxide isozymes. Characterization, purification, molecular cloning, and functions. Hypertension 23, 1121-1131.
22. GARCIA-CARDENA, G., OH, P., LIU, J., SCHNITZER, J. E. & SESSA, W. C. (1996). Targeting of nitric oxide synthase to endothelial cell caveolae via palmitoylation: Implications for nitric oxide signaling. Proceedings of the National Academy of Sciences of the USA 93, 6448-6453.
23. GARG, U. C. & HASSID, A. (1989). Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. Journal of Clinical Investigation 83, 1174-1777.
24. GEIGER, J., NOLTE, C., BUTT, E., SAGE, S. O. & WALTER, U. (1992). Role of cGMP and cGMP-dependent protein kinase in nitrovasodilator inhibition of agonist-evoked calcium elevation in human platelets. Proceedings of the National Academy of Sciences of the USA 89, 1031-1035.
25. 2+ in human aortic endothelial cells. European Journal of Pharmacology 314, 185-192.
26. GUKOVSKAYA, A. & PANDOL, S. J. (1994). Nitric oxide production regulates cGMP formation and calcium influx in pancreatic acinar cells. American Journal of Physiology 11, 477-486.
27. HECKER, M., MULSCH, A., BASSENGE, E., FORSTERMANN, E. & BUSSE, R. (1994). Subcellular localization and characterization of nitric oxide synthase(s) in endothelial cells: Physiological implications. Biochemical Journal 299, 247-252.
28. HOBBS, A. J., HIGGS, A. & MONCADA, S. (1999). Inhibition of nitric oxide synthase as a potential therapeutic target. Annual Reviews in Pharmacology and Toxicology 39, 191-220.
29. 3-sensitive stores using the fluorescent indicator mag-fura-2. Proceedings of the National Academy of Sciences of the USA 90, 2598-2602.
30. HOLDA, J. R., KLISHIN, A., SEDOVA, M., HÜSER, J. & BLATTER, L. A. (1998). Capacitative calcium entry. News in Physiological Sciences 13, 157-163.
31. IGARASHI, J., THATTE, H. S., PRABHAKAR, P., GOLAN, D. E. & MICHEL, T. (1999). Calcium-independent activation of endothelial nitric oxide synthase by ceramide. Proceedings of the National Academy of Sciences of the USA 96, 12583-12588.
32. 2+ release elicited by inositol trisphosphate but not caffeine in rat vascular smooth muscle. Journal of Pharmacology and Experimental Therapeutics 285, 16-21.
33. JULOU-SCHAEFFER, G., GRAY, G. A., FLEMING, I., SCHOTT, C., PARRATT, J. R. & STOCLET, J. C. (1990). Loss of vascular responsiveness induced by endotoxin involves L-arginine pathway. American Journal of Physiology 259, H1038-1043.
34. KANAZAWA, K., KAWASHIMA, S., MIKAMI, S., MIWA, Y., HIRATA, K., SUEMATSU, M., HAYASHI, Y., ITOH, H. & YOKOYAMA, M. (1996). Endothelial constitutive nitric oxide synthase protein and mRNA increased in rabbit atherosclerotic aorta despite impaired endothelium-dependent vascular relaxation. American Journal of Pathology 148, 1949-1956.
35. 2+ pump in endothelium. American Journal of Physiology 274, C1117-1128.
36. KOJIMA, H., NAKATSUBO, N., KIKUCHI, K., KAWAHARA, S., KIRINO, Y., NAGOSHI, H., HIRATA, Y. & NAGANO, T. (1998). Detection and imaging of nitric oxide with novel fluorescent indicators: Diaminofluoresceins. Analytical Chemistry 70, 2446-2453.
37. KUBES, P., SUZUKI, M. & GRANDER, D. N. (1991). Nitric oxide: An endogenous modulator of leukocyte adhesion. Proceedings of the National Academy of Sciences of the USA 88, 4651-4655.
38. KWAN, H. Y., HUANG, Y. & YAO, X. (2000). Store-operated calcium entry in vascular endothelial cells is inhibited by cGMP via a protein kinase G-dependent mechanism. Journal of Biological Chemistry 275, 6758-6763.
39. LI, H. & FORSTERMANN, U. (2000). Nitric oxide in the pathogenesis of vascular disease. Journal of Pathology 190, 244-254.
40. LI, L., BRESSLER, B., PRAMEYA, R., DOROVINI-ZIS, K. & VAN BREEMEN, C. (1999). Agonist-stimulated calcium entry in primary cultures of human cerebral microvascular endothelial cells. Microvascular Research 57, 211-226.
41. 2+ entry. Journal of Biological Chemistry 275, 17979-17985.
42. MA, X. L., LOPEZ, B. L., CHRISTOPHER, T. A., BIRENBAUM, D. S. & VINTEN-JOHANSEN, J. (1996). Exogenous NO inhibits basal NO release from vascular endothelium in vitro and in vivo. American Journal of Physiology 271, H2045-2051.
43. MONCADA, S., PALMER, R. M. & HIGGS, E. A. (1991). Nitric oxide: Physiology, pathophysiology, and pharmacology. Pharmacological Reviews 43, 109-142.
44. 2+-ATPase in human umbilical vein endothelial cells. Journal of Physiology 513, 83-101.
45. NAKATSUBO, N., KOJIMA, H., KIKUCHI, K., NAGOSHI, H., HIRATA, Y., MAEDA, D., IMAI, Y., IRIMURA, T. & NAGANO, T. (1998). Direct evidence of nitric oxide production from bovine aortic endothelial cells using new fluorescence indicators: Diaminofluoresceins. FEBS Letters 427, 263-266.
46. 2+ entry in human platelets is resistant to nitric oxide. Biochemical and Biophysical Research Communications 212, 90-96.
47. PRABHAKAR, P., THATTE, H. S., GOETZ, R. M., CHO, M. R., GOLAN, D. E. & MICHEL, T. (1998). Receptor-regulated translocation of endothelial nitric-oxide synthase. Journal of Biological Chemistry 273, 27383-27388.
48. RADOMSKI, M. W., PALMER, R. M. & MONCADA, S. (1987). The antiaggregating properties of vascular endothelium: Interactions between prostacyclin and nitric oxide. British Journal of Pharmacology 92, 639-646.
49. 2+ PUMP of bovine pulmonary artery. Cell Calcium 11, 261-268.
50. ROGERS, N. E. & IGNARRO, L. J. (1992). Constitutive nitric oxide synthase from cerebellum is reversibly inhibited by nitric oxide formed from L-arginine. Biochemical and Biophysical Research Communications 189, 242-249.
51. 2+ entry in bovine vascular endothelial cells. Cell Calcium 25, 333-343.
52. 2+ store depletion in bovine vascular endothelial cells. Journal of Physiology 523, 549-559.
53. 2+-ATPase. Proceedings of the National Academy of Sciences of the USA 87, 2466-2470.
54. 2+ stores. Circulation Research 84, 201-209.
55. 2+ by sarcoplasmic reticulum in vascular smooth muscle. Circulation Research 62, 961-964.
56. 2+-ATPase activity in rat megakaryocytes. European Journal of Pharmacology 347, 355-361.
57. 2+ transient in vascular smooth muscle cells in coculture. Journal of Biological Chemistry 271, 5647-5655.
58. 2+ influx. Journal of Biological Chemistry 269, 12645-12653.